Gilead Sciences Research Scholars Programs

The Gilead Sciences Research Scholars Programs ( ) provide financial support to junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report and approval by the Scientific Review Committee Chair. Recipients of these competitive awards are selected by Committees comprised of leaders in the fields of pulmonary arterial hypertension, cardiovascular disease, cystic fibrosis, hematology/oncology, and liver disease.  For a complete overview of the program, please go to:


The mission of the Gilead Sciences Research Scholars Program in Hematology/Oncology (the “program”) is to support innovative scientific research that will advance knowledge in the field of hematology/oncology and provide support for research career development. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding in hematology/oncology.


Submission Deadline: Midnight, Eastern Daylight Time, September 5, 2014. No applications will be accepted after this date.


Applications must be completed online and submitted electronically with the required Supplementary Materials.


If you have any questions, or require further information, please contact:


Research Scholars Program Coordinator

Telephone: 646-674-1820



Applicants must complete the online Application Form (all fields must be completed or applicant will not be able to submit) and include the following Supplementary Materials as specified:


    Research Abstract – No more than 325 words

    Research Proposal – No more than 5 pages, not including the bibliography or budget, using 11 point Arial font or larger, and single-spaced

    Applicant’s NIH biosketch, inclusive of publications, if applicable

    Mentor’s NIH biosketch

    Letter of Support from mentor which includes a track record of productivity, funding, and success; descriptions of planned interaction with the applicant, and available resources at the institution

    Bibliography of relevant references (maximum of 40)

    Detailed budget and completed budget summary

    Acknowledgement of Indirect Costs Limitation, using the template provided (Download Acknowledgement of Indirect Costs Limitation Template)

    Certification of Faculty Appointment, using the template provided (Download Certification of Faculty Appointment Template)

    Current or Pending Applications for Funding, using the template provided (Download Current or Pending Applications for Funding Template)

Alex’s Lemonade Stand Foundation Invites Letters of Intent Through Psychosocial Grant Program

LOI Deadline:  July 18,2014

The Alex’s Lemonade Stand Foundation is accepting Letters of Intent for two categories of grants through its Psychosocial Grant program.

1) Psychosocial Launch Grants  are designed for early career researchers within seven years of receiving their terminal degree. Grants of up to $100,000 over two years will be awarded in support of studies that aim to explain and/or improve psychosocial outcomes of individuals affected by childhood cancer.

2) Psychosocial Family Impact Grants are designed for established investigators. Grants of up to $300,000 over three years will be awarded in support of studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. Grants are designed to fund researchers with novel approaches to understanding the psychosocial aspects of pediatric cancer and whose proposals will have clinically significant impact.

The foundation will only consider LOIs from United States or Canadian nonprofit institutions. However, the principal investigator need not be a U.S. citizen.

For complete program guidelines and application instructions, visit the ALSF website.

Uniting Against Lung Cancer Announces Research Funding Opportunity

Deadline:  August 13, 2014

Uniting Against Lung Cancer, a nonprofit organization dedicated to providing funding for innovative research, has issued a Request for Proposals for its Legacy Program, the goal of which is to fund lung cancer research that can improve treatment and lead to a cure. In 2013, UALC awarded more than $1.5 million in research grants and expects to increase its support for research in 2014.

The program prioritizes novel ideas with the potential to make a significant impact on current treatment of lung cancer and patient survival, and places a high priority on funding research that demonstrates a clear path to improving patient care. Cross-disciplinary collaborations are strongly encouraged.

Areas of interest include but are not limited to developing novel therapies with the potential to cure lung cancers, genetic subsets of lung cancer/personalized medicine, primary and secondary drug sensitivity/resistance, lung cancer in never-smokers, improving outcomes in early-stage disease, and small-cell lung cancer.

Awards will range up to $100,000, to be paid over two years.

Investigators at all levels are encouraged to apply. While collaborations with industry partners are strongly encouraged, the principal investigator must be an academic researcher.

Visit the UALC website for the complete Request for Proposals and application materials